179 related articles for article (PubMed ID: 38347489)
1. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.
Tao S; Cui D; Cheng H; Liu X; Jiang Z; Chen H; Gao Y
BMC Cancer; 2024 Feb; 24(1):194. PubMed ID: 38347489
[TBL] [Abstract][Full Text] [Related]
2. PDCD6 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis through the AKT/GSK3β/β-catenin Pathway.
Wen SY; Liu YT; Wei BY; Ma JQ; Chen YY
Biomed Environ Sci; 2023 Mar; 36(3):241-252. PubMed ID: 37005078
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma.
Li J; Tuo D; Guo G; Gan J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15763-15779. PubMed ID: 37668796
[TBL] [Abstract][Full Text] [Related]
4. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
Liu Y; Ma J; Lu S; He P; Dong W
Chin Med J (Engl); 2023 Sep; 136(18):2229-2242. PubMed ID: 37439386
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
6. DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling.
Zhou H; Du Y; Wei X; Song C; Song J; Xu N; Huang W; Chen L; Yao F; Du D; Qiu C; Zhong L; Liu Y; Gu D; Wang J; Xu Y
Theranostics; 2022; 12(14):6069-6087. PubMed ID: 36168636
[No Abstract] [Full Text] [Related]
7. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
9. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
10. miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK.
Hu Z; Li L; Li M; Zhang X; Zhang Y; Ran J; Li L
J Immunol Res; 2023; 2023():8929525. PubMed ID: 37008632
[TBL] [Abstract][Full Text] [Related]
11. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
[TBL] [Abstract][Full Text] [Related]
12. Hydrogel-based miR-192 delivery inhibits the development of hepatocellular carcinoma by suppressing the GSK3β/Wnt/β-catenin pathway.
Yang Q; Zhuge X; Lin W; Yu W; Zhu Y; Shi C; Shi Z
Neoplasma; 2023 Aug; 70(4):555-565. PubMed ID: 37789778
[TBL] [Abstract][Full Text] [Related]
13. CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway.
Wang C; Cao F; Cao J; Jiao Z; You Y; Xiong Y; Zhao W; Wang X
J Transl Med; 2023 Aug; 21(1):539. PubMed ID: 37573318
[TBL] [Abstract][Full Text] [Related]
14. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
[TBL] [Abstract][Full Text] [Related]
16. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.
Zhang T; Ma Z; Liu L; Sun J; Tang H; Zhang B; Zou Y; Li H
Cell Death Dis; 2018 Jun; 9(6):675. PubMed ID: 29867138
[TBL] [Abstract][Full Text] [Related]
17. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
18. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
Zhu L; Yang X; Feng J; Mao J; Zhang Q; He M; Mi Y; Mei Y; Jin G; Zhang H
J Transl Med; 2022 May; 20(1):194. PubMed ID: 35509083
[TBL] [Abstract][Full Text] [Related]
20. High expression of DHX9 promotes the growth and metastasis of hepatocellular carcinoma.
Shi F; Cao S; Zhu Y; Yu Q; Guo W; Zhang S
J Clin Lab Anal; 2021 Dec; 35(12):e24052. PubMed ID: 34676915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]